Tumor Marker Expression
Showing 1 - 25 of >10,000
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
Not yet recruiting
- Cervical Cancer
- Detection of serum AUNIP expression
- (no location specified)
Nov 6, 2023
ALDH1A1 Expression in Invasive Mammary Carcinoma
Enrolling by invitation
- Breast Cancer
-
Sohag, EgyptFaculty of Medicine
Nov 12, 2023
CXCL5 asValuable Prognostic Marker in Urinary Bladder Urothelial
Recruiting
- Urinary Bladder Urothelial Carcinoma
-
Sohag, EgyptFaculty of Medicine, Sohag University
Jul 26, 2022
1 asPotential Biomarker for Colorectal Cancer Diagnosis and
Not yet recruiting
- Colorectal Cancer
- Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
- (no location specified)
Mar 20, 2023
Bladder Cancer Trial (urinary micro RNA detection)
Not yet recruiting
- Bladder Cancer
- urinary micro RNA detection
- (no location specified)
Jan 15, 2023
HER2-positive Advanced Breast Cancer Patients Treated With ADC
Recruiting
- Breast Cancer
- HER2 expression of circulating tumor cells
-
Beijing, Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Apr 18, 2023
HER2-low Advanced Breast Cancer Patients Treated With ADC
Recruiting
- Breast Cancer
- HER2 expression of circulating tumor cells
-
Beijing, Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Apr 18, 2023
Pancreas Cancer Trial (mRNA expression)
Not yet recruiting
- Pancreas Cancer
- mRNA expression
- (no location specified)
Aug 8, 2022
Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals
Not yet recruiting
- Preterm Labor
- (no location specified)
May 9, 2023
HLA-DR in Cell Cultures Isolated From Primary Squamous Cell
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cancer
- cell culture
-
Roma, Lazio, ItalyFondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023
Ovarian Cancer Trial in Boston (Zafirlukast)
Recruiting
- Ovarian Cancer
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Nov 11, 2022
Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaBiyun Wang, MD
Apr 5, 2023
Solid Tumor Trial (Disitamab vedotin)
Not yet recruiting
- Solid Tumor
- Disitamab vedotin
- (no location specified)
Jul 10, 2023
Lung Cancer Circulating Tumor Cells
Not yet recruiting
- Non Small Cell Lung Cancer
- Sample
-
Nice, FranceCHU de Nice
Dec 5, 2022
Coplanar Template Assistance for Abdominal Tumor Puncture
Recruiting
- Abdominal Tumor
-
Beijing, ChinaDepartment of Radiation Oncology of Peking university third hosp
Jul 18, 2022
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in
Not yet recruiting
- Head and Neck Cancer
- +8 more
- Tumor and HLA Profiling
- (no location specified)
Mar 31, 2023
Soft Tissue Sarcoma Trial in Guangzhou (TAEST16001 cells)
Active, not recruiting
- Soft Tissue Sarcoma
- TAEST16001 cells
-
Guangzhou, Guangdong, ChinaXing Zhang
Dec 13, 2022
Anogenital Wart Trial in Makassar (Topical Ethanol Extract (Piper crocatum), Trichloroacetic Acid Topical)
Not yet recruiting
- Anogenital Wart
- Topical Ethanol Extract (Piper crocatum)
- Trichloroacetic Acid Topical
-
Makassar, South Sulawesi, IndonesiaWahidin Sudirohusodo General Hospital
Nov 14, 2022
The First Affiliated Hospital of Nanchang University Trial in Nanchang, Jinan (Orelabrutinib+R-CHOP)
Recruiting
- The First Affiliated Hospital of Nanchang University
-
Nanchang, Jiangxi, China
- +1 more
Jul 3, 2023
Cancer Colon Trial in Sohag (immunohistochemical staining)
Completed
- Cancer Colon
- immunohistochemical staining
-
Sohag, EgyptMaisa Hashem Mohammed
Jul 13, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)
Recruiting
- Gastrointestinal Stromal Tumors
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Chinahongshan Hospital Affiliated to Fudan University
Sep 14, 2023
Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +
Not yet recruiting
- Breast Cancer
- +3 more
- AI+CDK4/6i
- +7 more
-
Miami, FloridaUniversity of Miami
Apr 12, 2023